a<p>“Correlated” uptake refers to a situation where vaccine uptake within the population is correlated with factors which also affect choice of sexual partners. “Unrelated” uptake refers to a situation where vaccine uptake is unrelated to any of these factors.</p>b<p>A pseudo Gini coefficient closer to zero represents more equal outcomes between subgroups; a pseudo Gini coefficient closer to the theoretical maximum represents more unequal outcomes between subgroups. Theoretical maxima for pseudo Gini coefficients are 0.8766 (“Australia” scenario), 0.8378 (“USA” scenario) and 0.5 (“extreme inequality” scenario).</p>c<p>RR<sub>L</sub> is the risk experienced by the subgroup with the lowest vaccine coverage relative to that in the subgroup wit...
<div><p>(A) The effect of routinely vaccinating successive cohorts of men and women compared to vacc...
<div><p>Background</p><p>Vaccines against HPV16/18 are approved for use in females and males but mos...
(A) HPV Vaccine Initiation Coverage Rates, (B) HPV Vaccine UTD Coverage Rates.</p
Vaccines against HPV16/18 are approved for use in females and males but most countries currently hav...
<p>Unless otherwise stated, the results pertain to females under the base-case scenario. (a) The mod...
<p>Results are presented as N (%)/N(%) for number and percent for the tested category versus number ...
Background: Vaccines against HPV16/18 are approved for use in females and males but most countries c...
Background: The immunogenicity profile of the 9-valent HPV (9vHPV) vaccine was evaluated across five...
Concern has been expressed that human papillomavirus (HPV) vaccination programs might promote risky ...
The base-case estimates of ultimate reductions in anal HPV16 infection prevalence among MSM by vacci...
BACKGROUND: The immunogenicity profile of the 9-valent HPV (9vHPV) vaccine was evaluated across five...
Vaccines against HPV16/18 are approved for use in females and males but most countries currently hav...
<div><p>The vaccination coverage dynamic has a memory parameter <i>s</i> = 0.7, an adaptability para...
Item does not contain fulltextBACKGROUND: Mathematical modelling is used to estimate the effectivene...
Objectives Gini coefficients have been used to describe the distribution of Chlamydia trachomatis...
<div><p>(A) The effect of routinely vaccinating successive cohorts of men and women compared to vacc...
<div><p>Background</p><p>Vaccines against HPV16/18 are approved for use in females and males but mos...
(A) HPV Vaccine Initiation Coverage Rates, (B) HPV Vaccine UTD Coverage Rates.</p
Vaccines against HPV16/18 are approved for use in females and males but most countries currently hav...
<p>Unless otherwise stated, the results pertain to females under the base-case scenario. (a) The mod...
<p>Results are presented as N (%)/N(%) for number and percent for the tested category versus number ...
Background: Vaccines against HPV16/18 are approved for use in females and males but most countries c...
Background: The immunogenicity profile of the 9-valent HPV (9vHPV) vaccine was evaluated across five...
Concern has been expressed that human papillomavirus (HPV) vaccination programs might promote risky ...
The base-case estimates of ultimate reductions in anal HPV16 infection prevalence among MSM by vacci...
BACKGROUND: The immunogenicity profile of the 9-valent HPV (9vHPV) vaccine was evaluated across five...
Vaccines against HPV16/18 are approved for use in females and males but most countries currently hav...
<div><p>The vaccination coverage dynamic has a memory parameter <i>s</i> = 0.7, an adaptability para...
Item does not contain fulltextBACKGROUND: Mathematical modelling is used to estimate the effectivene...
Objectives Gini coefficients have been used to describe the distribution of Chlamydia trachomatis...
<div><p>(A) The effect of routinely vaccinating successive cohorts of men and women compared to vacc...
<div><p>Background</p><p>Vaccines against HPV16/18 are approved for use in females and males but mos...
(A) HPV Vaccine Initiation Coverage Rates, (B) HPV Vaccine UTD Coverage Rates.</p